About Wanbury Limited
Wanbury Limited is a company based in Mumbai (India) founded in 1990. The company has 1,380 employees as of March 31, 2024. Wanbury Limited operates in a competitive market with competitors including Almac Group, Indoco Remedies, Concord Biotech, BDR Pharmaceuticals Internationals and Aurobindo Pharma, among others.
- Headquarter Mumbai, India
- Employees 1380 as on 31 Mar, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Wanbury Limited
-
Annual Revenue
$69.64 M (USD)3.4as on Mar 31, 2025
-
Net Profit
$3.57 M (USD)-45.44as on Mar 31, 2025
-
EBITDA
$8.44 M (USD)8.56as on Mar 31, 2025
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
1380
as on Mar 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Wanbury Limited
Wanbury Limited is a publicly listed company on the NSE with ticker symbol WANBURY in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
People of Wanbury Limited
Unlock access to complete
Funding Insights of Wanbury Limited
Detailed funding history for Wanbury Limited
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Wanbury Limited
Investment portfolio details for Wanbury Limited
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Wanbury Limited
Detailed financials for Wanbury Limited
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Wanbury Limited Comparisons
Peer comparison for Wanbury Limited
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Wanbury Limited
Wanbury Limited operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Almac Group, Indoco Remedies, Concord Biotech, BDR Pharmaceuticals Internationals and Aurobindo Pharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Integrated CDMO services for biopharma R&D and manufacturing are offered.
|
|
| Locked | Locked | Locked |
APIs manufacturing and formulation services are provided in therapeutic segments.
|
|
| Locked | Locked | Locked |
APIs and enzymes are manufactured through fermentation by the CDMO.
|
|
| Locked | Locked | Locked |
APIs and finished products are developed and manufactured.
|
|
| Locked | Locked | Locked |
Generic biocatalytic solutions are provided for pharmaceutical applications.
|
|
| Locked | Locked | Locked |
APIs and peptides are developed and manufactured by Asymchem.
|
Detailed competitors of Wanbury Limited
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Wanbury Limited
Complete news archive for Wanbury Limited
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Wanbury Limited
Wanbury Limited was founded in 1990.
Wanbury Limited is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
As of Mar 31, 2024, the latest employee count at Wanbury Limited is 1,380.
Annual revenue of Wanbury Limited is $69.64M as on Mar 31, 2025.
Wanbury Limited was founded in 1990 and is headquartered in Mumbai, India. Operations are centered in the pharmaceutical sector, with a focus on producing active pharmaceutical ingredients for anti-diabetic treatments. Metformin is among the key products, which aids in insulin response and blood sugar regulation by limiting glucose absorption and liver production. The company maintains a notable position in the industry through its manufacturing processes.
Wanbury Limited's top competitors include Concord Biotech, BDR Pharmaceuticals Internationals and Almac Group.
Yes, Wanbury Limited is publicly traded on NSE under the ticker symbol WANBURY.
The ticker symbol of Wanbury Limited is WANBURY on NSE.